What to Look For in Treatment Centers for Addiction

treatment centers addiction
Written by the Clinical Team at Oregon Trail Recovery, a trusted provider of drug and alcohol rehab in Portland, Oregon. Our experienced staff specializes in evidence-based addiction treatment, long-term recovery support, and compassionate care for individuals and families across the Pacific Northwest.

Key Takeaways

  • A polished campus doesn't predict recovery. Ask about accreditation, evidence-based therapies, medication access, and how treatment plans get revised, because the clinical spine is what holds after discharge 5.
  • Programs that dodge questions about buprenorphine, naltrexone, or acamprosate are prioritizing philosophy over evidence. Confirm who prescribes, whether medications are on site or coordinated, and how continuity is protected 11, 2.
  • Depression, PTSD, and anxiety don't wait their turn behind substance use. Insist on integrated mental health assessment and trauma-focused therapy delivered by the same clinical team, not referred out 11, 5.
  • The week after detox is the highest-risk window. CMS expects a qualifying follow-up within 7 days and 14 as the outer limit, so require a confirmed appointment before discharge, not a referral list 8.
  • Marketing claims aren't outcomes. Ask for retention numbers against the CMS initiation and engagement benchmarks, where state means were 46% and 17.3%, to see whether a program measures its own reality 6, 9.
  • IOP isn't a step-down consolation. Matched to the right client, 50% to 70% report abstinence at follow-up, so evaluate clinical hours, therapies delivered, and medication coordination as rigorously as residential 10, 3.
  • Discharge day isn't the finish line. Continuing care should run 3 to 6 months, often up to 12, with real clinical contact and relapse monitoring, not just a monthly alumni Zoom 12.
  • Families notice the early warning signs first. Demand structured family sessions with a clinician, relapse-warning education, and a named contact for after-hours concerns, not a once-a-month family night 4, 1.

The Evaluation Mistakes That Quietly Predict Relapse

You've probably already noticed something uncomfortable about picking a treatment center: the programs that look the most polished aren't always the ones that hold up after discharge. The tour is warm. The website mentions trauma-informed care. Someone says the word "holistic." And then, six weeks after the last group, the person you love is right back where they started.

That gap between what a program sells and what it actually delivers is where relapse quietly gets built. And it's rarely built by one big failure. It's built by small evaluation mistakes made in a moment when you're exhausted, scared, and running out of time to decide.

Here's the shift this piece asks you to make. Stop asking "what does this program offer?" and start asking "what would this program refuse to overlook?" Federal agencies have actually done a lot of the work for you. SAMHSA published 12 questions worth asking any program before you sign paperwork 1. NIDA distilled it further into five 2. Researchers have synthesized those into consumer-facing "signs of higher-quality treatment" that map directly onto what predicts sustained recovery 5.

What follows is a walk through the eight mistakes that show up again and again when families evaluate Oregon addiction treatment, Portland IOPs, or Wyoming drug rehab options, plus one section for referring professionals doing this work every week. Each mistake gets named plainly, then paired with the evidence-based correction. No filler. No shame. Just the questions worth refusing to skip.

Mistake 1: Trusting the Building Instead of the Clinical Spine

A beautiful campus is not a treatment plan. You can walk into a place with reclaimed wood, a chef, and a view of Mount Hood, and still be looking at a program that hasn't updated its clinical model in a decade. The building sells itself in an afternoon. The clinical spine takes longer to see, which is exactly why people skip checking it.

The federal synthesis of higher-quality treatment gives you a short list of things a program either has or doesn't have. It's not vibes:

  • Accreditation.
  • Evidence-based behavioral therapies.
  • FDA-approved medications actually available on site or through a clear prescriber relationship.
  • Attention to co-occurring mental and physical health needs.
  • An individualized treatment plan that gets revised as you go.
  • Adequate duration.
  • A real continuing care plan.
  • Family involvement built into the clinical work, not tacked on as a Sunday visit 5.

Notice what's not on that list: square footage, equine therapy, sound baths, or the phrase "luxury." Those aren't disqualifying. They're just not what predicts whether someone stays in recovery.

Here's the honest part. When you're exhausted and someone in your family is in crisis, the pretty campus feels like reassurance. That's a real feeling and it's okay to have it. But the questions that actually protect your person are boring ones. Who accredits you? Which therapies do your clinicians deliver? Do you prescribe or coordinate buprenorphine and naltrexone? What does the treatment plan look like on day 30, and who rewrites it?

If a program can't answer those in plain language, the building isn't the problem. The spine is.

Mistake 2: Accepting a Program That Won't Discuss Medications

If you bring up buprenorphine, naltrexone, or acamprosate on a tour and the response gets vague, that's information. Not a small piece of information. A big one.

NIDA's principles guide is direct about this: medications are a core component of evidence-based treatment for opioid and alcohol use disorders, and programs that don't offer them, or won't coordinate them, are working against the science 11. SAMHSA's evaluation questions include medication access on the short list for a reason 1. NIDA's five-question brochure asks flatly whether the program provides medications as part of the treatment plan 2. This isn't a niche preference. It's a federal quality signal.

You'll hear a few versions of the dodge:

  • "We're an abstinence-based program."
  • "We prefer clients get stable first."
  • "That's more of a medical decision, so we don't really get into it."

Each of those sentences is a way of telling you the program has decided its philosophy matters more than what the evidence says protects your person from overdose and relapse. For opioid use disorder in particular, that's a decision with a body count.

The correction is straightforward. Ask who prescribes. Ask whether medications like buprenorphine or naltrexone are available on site or through a named prescriber the program actually coordinates with. Ask what happens if someone arrives already stabilized on medication, because the answer tells you whether continuity is respected or quietly discouraged.

You're allowed to walk away from a program that treats FDA-approved medications as optional. Recovery is hard enough without fighting your own treatment team for tools that work.

Mistake 3: Treating Co-Occurring Mental Health as an Add-On

If a program treats depression, PTSD, or anxiety like something they'll get to after the substance use is "handled," you're looking at a setup for relapse. The two don't wait their turn. They feed each other in real time.

NIDA's Principles guide is unambiguous here: integrated treatment for co-occurring mental disorders is a core principle of effective addiction care, not an enhancement package 11. The federal signs of higher-quality treatment name attention to mental and physical health needs as one of the defining characteristics of programs that actually work 5. SAMHSA's evaluation questions specifically ask whether a program encompasses the full range of an individual's needs, including psychological ones 1.

What this looks like in practice matters more than the marketing. Ask who does the mental health assessment and when. Ask whether trauma-focused therapies like Seeking Safety or CBT for PTSD are actually delivered by clinicians on the team, or whether the program refers out and hopes it happens. Ask what the plan is when someone's anxiety spikes in week three and starts pulling them toward use. If the answer is "we'd send them to their outside provider," you don't have integrated care. You have parallel care that will drift apart the first time it's tested.

Across the Pacific Northwest, and especially in thinner networks like Central Oregon or Wyoming mental health resources, referring out often means a six-week wait. Six weeks is a relapse window. Integration on the same clinical team closes it.

Mistake 4: Letting the Detox-to-Next-Step Handoff Slip

The most dangerous week in someone's recovery is often the one right after detox ends. The physical crisis is over. The clinical structure disappears. And if nothing is already scheduled, that empty calendar starts filling itself in with the old routine.

This is the mistake that quietly undoes a lot of good work. A family drives someone to medically managed withdrawal, feels a wave of relief when discharge day comes, and assumes "the next step" will get sorted out in a phone call or two. Meanwhile, the person who just went through withdrawal is home, tender, and unstructured. That gap is where relapse lives.

CMS has actually put a number on how fast that handoff needs to happen. Their continuity-of-care measure for substance use disorder treatment expects a qualifying follow-up service, meaning an outpatient visit, an intensive outpatient encounter, partial hospitalization, a telehealth session, or a filled prescription for an SUD medication, within 7 days of discharge from medically managed withdrawal, with 14 days as the outer window 8. Not "soon." Not "once we sort out insurance." Seven days.

Hold any program you're evaluating to that clock. Before detox even starts, ask three plain questions:

  1. Who books the next appointment, and when?
  2. Is that appointment already on the calendar before discharge, or is it a phone number on a piece of paper?
  3. If medication was started, who is prescribing on day 8, day 15, and day 30?

If a program tells you they'll "give you referrals" at discharge, you don't have a handoff. You have a shrug. Referrals are lists. Handoffs are warm, scheduled, and confirmed while the person is still in the building.

This matters more in some parts of the Pacific Northwest than others. In Portland, IOP density is high enough that a same-week slot is usually findable if someone is actually working the phones on your behalf. In Central Oregon and across much of Wyoming, the network is thinner, and a program that waits until discharge day to start looking is going to blow past the 14-day window without much effort. Ask specifically how the program handles handoffs when the closest IOP has a two-week waitlist. If the answer is telehealth, that's a legitimate qualifying service under the CMS definition 8. If the answer is a stammer, keep looking.

Mistake 5: Measuring a Program by the Brochure, Not the Benchmarks

Every program tells you it works. That's not a lie, exactly. It's just a claim without a denominator. The mistake here is accepting outcome language at face value instead of asking what regulators already measure, and how the program stacks up against those benchmarks.

CMS tracks two numbers worth knowing. The Initiation and Engagement of Substance Use Disorder Treatment measure asks whether a new SUD episode results in a real treatment contact within 14 days, and then whether that person stays engaged with at least two more qualifying services within 34 days 6. It's a mandatory adult core set measure for 2026, which means Medicaid programs across Oregon, Washington, and Wyoming are increasingly held to it 7.

Here's the part that should reframe how you evaluate any center. In the 2024 publicly reported Adult Core Set data, the state mean for initiation within 14 days was 46%, and the state mean for engagement within 34 days was 17.3%, for total SUD 9. That's Medicaid-covered episodes across reporting states, not a single program's outcomes, and it measures process rather than long-term abstinence. But the drop-off tells you something. Fewer than one in five new episodes tracked by CMS turned into sustained engagement in the first month. Most systems are losing people between the front door and the fourth appointment.

Use that gap as a question. Ask a program flatly:

  • What percentage of the people who start with you are still showing up at week five?
  • What's your no-show rate after intake?
  • How many clients complete the level of care they were admitted to?

A program that has never looked at its own retention numbers is a program that can't tell you whether its brochure matches its reality.

You're not being difficult by asking. You're using the same lens federal payers use. And if the answer is a shrug or a redirect back to testimonials, the benchmark just told you what the brochure wouldn't.

Mistake 6: Treating IOP as a Downgrade Instead of a Destination

There's a story families tell themselves that sounds reasonable and isn't quite true: residential is the "real" treatment, and intensive outpatient is what happens on the way out the door. It's a downgrade. A step down. Somewhere between recovery and being on your own.

The evidence doesn't support that framing. A systematic review of intensive outpatient programs found that 50% to 70% of participants reported abstinence at follow-up, and outcomes did not meaningfully differ between inpatient and outpatient settings when people were matched to the right level of care 10. That's not a small finding tucked into a footnote. That's the actual state of the research, and it should reshape how you weigh a program that leads with its IOP versus one that treats outpatient care like a consolation prize.

What that matching phrase means in practice is worth slowing down on. IOP works when the person has stable housing, a functional support system, and a clinical spine that includes real behavioral therapy, medication access, and monitoring 3. It works less well when someone is discharged from detox into an empty apartment with a group schedule and no one calling if they don't show up. The setting isn't the variable. The structure is.

So when you're evaluating an IOP in Portland, Bend, or a smaller Wyoming network, ask what it actually does with the time:

The framing shift matters because it changes what you're willing to hold out for. If you think of IOP as a stepping-stone to "nothing," you'll accept a thin version of it. If you think of it as an evidence-based destination, likely lasting several months and often the setting where the actual recovery skills get built, you'll ask the harder questions and refuse the weaker programs. That's the correction here. Not less intensive care. Differently structured care, held to the same clinical bar as anything that came before it.

Real Recovery Starts in Portland, Oregon

If you’re looking for help—for yourself, someone you care about, or a client—you’re probably not looking for another temporary fix. At Oregon Trail Recovery, we combine structure, accountability, and real-life skill building to help people stay sober long after treatment ends.

‍Call now or verify insurance to take the first step toward lasting recovery in Portland.
Call Admissions

Mistake 7: Ending Aftercare When the Calendar Says the Program Ended

Discharge day is not a finish line. It feels like one, which is part of the problem. Everyone exhales. The paperwork gets signed. And the clinical work that actually protects against relapse either continues in a real, structured way or it doesn't.

The mistake is treating aftercare like a courtesy call. A weekly alumni Zoom. A monthly check-in. Something that trails off around week six because the person seems fine. The peer-reviewed continuing care literature is blunt about the timeline that actually holds. Continuing care should last at least three to six months, and often up to twelve months, before the relapse risk curve meaningfully flattens 12. Not weeks. Months, plural, with real clinical contact inside them.

Ask any Oregon addiction treatment program or Wyoming drug rehab you're considering three plain questions about what happens after the main level of care ends:

  1. How long is the continuing care plan, in months?
  2. What does clinical contact look like at month four, month eight, month twelve?
  3. Who owns the relapse-monitoring piece, and what triggers a step back up in care if things start slipping?

If the honest answer is "we have an alumni group," that's community, not continuing care. Both matter. Only one is clinical. A program that ends its involvement the day the calendar says it should is telling you it doesn't plan to be there for the part of recovery where relapse actually happens.

Mistake 8: Leaving Families Out of the Clinical Plan

Families are often treated as a visiting policy instead of a clinical asset. That's the mistake. Somewhere along the way, "family involvement" got reduced to a Saturday afternoon and a resource packet, and everyone agreed to pretend that was enough.

The principles of intensive outpatient treatment name family and significant-other engagement as a core component of what actually works, not a nice-to-have 4. SAMHSA's evaluation questions specifically ask whether a program provides family services 1. The reason is practical. The people who live with your person are the ones who notice the sleep changes at week five, the friend who reappears at week seven, the quiet week that isn't quiet in the right way. If they're not trained, looped in, and given someone to call, that information doesn't reach the clinical team until after the relapse.

Ask specifically:

  • Are there structured family sessions built into the treatment plan, with a clinician present?
  • Is there education on what relapse warning signs actually look like?
  • Who does the family call at 9 p.m. on a Tuesday when something feels off?

If the answer is "we have a family night once a month," that's an event. Not a plan.

If You're a Referring Professional Vetting Programs

A quick scope shift: this section is written for case managers, referring clinicians, sober-living operators, and probation officers doing this evaluation on behalf of people they're accountable to. If you're a family reader, you can skim.

You already know the vocabulary, so here's the short version of what to keep in your intake packet. Ask every program for its own IET-style numbers, initiation within 14 days and engagement within 34 days, or the closest process equivalent it tracks internally 6. A program that can produce those numbers is telling you it measures itself against the same benchmarks your county Medicaid contract is measured against.

Ask about pharmacotherapy access as a matter of policy, not case-by-case: who prescribes buprenorphine and naltrexone, and how quickly a referred client can get on or stay on a medication after your handoff 8, 11. Ask about the 7-day continuity window after medically managed withdrawal in plain terms: will your client have a confirmed appointment before discharge, or a phone number?

Then use the quality-indicators framework as your mental rubric: structure, process, outcome, safety, equity, effectiveness, timeliness 13. If a program can only answer on structure, keep vetting.

How to Actually Run the Evaluation Before You Commit

You don't need a scoring rubric with weighted columns. You need a short, honest afternoon with a notebook and a phone.

Start with three calls, not one. Ask each program the same seven questions in the same order:

  1. Are you accredited, and by whom?
  2. Which evidence-based therapies do your clinicians actually deliver?
  3. Do you prescribe or coordinate buprenorphine and naltrexone on site?
  4. How do you handle the first appointment after detox, and is it booked before discharge?
  5. What does your continuing care plan look like at month six?
  6. How are families brought into the clinical work?
  7. What percentage of the people who start with you complete the level of care they were admitted to?

Those questions map directly onto the federal signs of higher-quality treatment and NIDA's core five 2, 5.

Then run the answers through the six-domain lens researchers use to evaluate SUD care: safety, effectiveness, patient-centeredness, equity, efficiency, and timeliness 13. A program that answers cleanly on structure but goes vague on timeliness or outcomes is telling you where the weak seam is.

One last thing. Trust the tone of the answers, not just the content. A program that welcomes hard questions is a program that expects to be measured. That's the one worth committing to, whether you're evaluating Oregon addiction treatment, a Portland IOP, or a Wyoming drug rehab for someone you love.

Frequently Asked Questions

What are the most important signs of a higher-quality addiction treatment center?

Look for accreditation, evidence-based behavioral therapies delivered by licensed clinicians, access to FDA-approved medications, integrated care for co-occurring mental health conditions, individualized treatment plans that get updated, adequate duration, real continuing care, and structured family involvement 5, 1. If a program can't answer plainly on those, the marketing is doing work the clinical spine isn't.

Should I be worried if a program won't discuss FDA-approved medications for addiction?

Yes. NIDA identifies medications like buprenorphine and naltrexone as a core component of evidence-based treatment, especially for opioid and alcohol use disorders 11. If a program dodges the question or frames medication as opposed to "real" recovery, that's a philosophy overriding the evidence. Ask who prescribes, whether it's on site or coordinated, and what happens if someone arrives already stabilized.

How quickly should someone connect to the next level of care after detox or residential treatment?

CMS's continuity-of-care measure expects a qualifying follow-up service, an outpatient visit, IOP encounter, partial hospitalization, telehealth session, or filled SUD prescription, within 7 days of discharge from medically managed withdrawal, with 14 days as the outer window 8. Insist the next appointment is booked before discharge, not handed over as a phone number on paper.

Is intensive outpatient (IOP) really as effective as residential treatment?

When people are matched to the right level of care, yes. A systematic review of IOPs found that 50% to 70% of participants reported abstinence at follow-up, and outcomes did not meaningfully differ between inpatient and outpatient settings 10. IOP isn't a downgrade. It's an evidence-based destination when the clinical structure, medication access, and monitoring are actually in place 3.

How long should aftercare or continuing care last to protect against relapse?

The peer-reviewed continuing care literature suggests at least 3 to 6 months, and often up to 12 months, of real clinical contact before the relapse risk curve meaningfully flattens 12. A monthly alumni Zoom is community, not continuing care. Ask a program what clinical involvement looks like at month four, month eight, and month twelve, and who triggers a step-up in care.

What questions should I ask when evaluating a treatment center for a family member?

Use NIDA's core five and SAMHSA's 12 as your backbone 2, 1. Ask about accreditation, which evidence-based therapies clinicians actually deliver, medication access, how the first appointment after detox gets booked, what continuing care looks like at six months, how families are brought into the clinical work, and what percentage of clients complete the level of care they started. Vague answers are answers.

References

  1. A Quick Guide to Finding Effective Alcohol and Drug Addiction Treatment. https://www.michigan.gov/-/media/Project/Websites/mdhhs/Folder2/Folder62/Folder1/Folder162/SAMHSA_Quick_Guide_Find_Treatment.pdf
  2. SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK. https://nida.nih.gov/sites/default/files/treatmentbrochure_web.pdf
  3. Substance Abuse: Clinical Issues in Intensive Outpatient Treatment. https://www.ncbi.nlm.nih.gov/books/NBK64093/
  4. Chapter 2. Principles of Intensive Outpatient Treatment. https://ncbi.nlm.nih.gov/sites/books/NBK64087/
  5. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality. https://www.ncbi.nlm.nih.gov/books/NBK559647/
  6. Overview of Substance Use Disorder Measures in the 2024 Child, Adult, and Health Home Core Sets. https://www.medicaid.gov/medicaid/quality-of-care/downloads/factsheet-sud-adult-core-set.pdf
  7. 2026 Core Set of Adult Health Care Quality Measures for Medicaid. https://www.medicaid.gov/medicaid/quality-of-care/downloads/2026-adult-core-set.pdf
  8. Reducing Substance Use Disorders: Quality Measures. https://www.medicaid.gov/resources-for-states/innovation-accelerator-program/functional-areas/quality-measurement/reducing-substance-use-disorders-quality-measures
  9. Performance Rates on Publicly Reported 2024 Adult Core Set (Substance Use Disorder Treatment Sections). https://www.medicaid.gov/medicaid/quality-of-care/downloads/summary-performance-table-adult-2024.pdf
  10. Substance Abuse Intensive Outpatient Programs: Assessing the Evidence. https://pmc.ncbi.nlm.nih.gov/articles/PMC4152944/
  11. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
  12. The Continuing Care Model of Substance Use Treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC4007701/
  13. Quality indicators for substance use disorder care. https://pmc.ncbi.nlm.nih.gov/articles/PMC11962784/
[{"@context":"https://schema.org","@type":"BlogPosting","headline":"What to Look For in Treatment Centers for Addiction","description":"Learn how to evaluate treatment centers addiction by focusing on evidence-based care, medication access, mental health integration, and lasting support.","publisher":{"@type":"Organization","name":"www.oregontrailrecovery.com"},"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.oregontrailrecovery.com"}},{"@context":"https://schema.org","@type":"MedicalWebPage","headline":"What to Look For in Treatment Centers for Addiction","description":"Learn how to evaluate treatment centers addiction by focusing on evidence-based care, medication access, mental health integration, and lasting support.","mainEntityOfPage":{"@type":"WebPage","@id":"https://www.oregontrailrecovery.com"}},{"@context":"https://schema.org","@type":"ItemList","itemListElement":[{"@type":"ListItem","position":1,"name":"Trusting the Building Instead of the Clinical Spine"},{"@type":"ListItem","position":2,"name":"Accepting a Program That Won't Discuss Medications"},{"@type":"ListItem","position":3,"name":"Treating Co-Occurring Mental Health as an Add-On"},{"@type":"ListItem","position":4,"name":"Letting the Detox-to-Next-Step Handoff Slip"},{"@type":"ListItem","position":5,"name":"Measuring a Program by the Brochure, Not the Benchmarks"},{"@type":"ListItem","position":6,"name":"Treating IOP as a Downgrade Instead of a Destination"},{"@type":"ListItem","position":7,"name":"Ending Aftercare When the Calendar Says the Program Ended"},{"@type":"ListItem","position":8,"name":"Leaving Families Out of the Clinical Plan"}]},{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What are the most important signs of a higher-quality addiction treatment center?","acceptedAnswer":{"@type":"Answer","text":"Look for accreditation, evidence-based behavioral therapies delivered by licensed clinicians, access to FDA-approved medications, integrated care for co-occurring mental health conditions, individualized treatment plans that get updated, adequate duration, real continuing care, and structured family involvement. If a program can't answer plainly on those, the marketing is doing work the clinical spine isn't."}},{"@type":"Question","name":"Should I be worried if a program won't discuss FDA-approved medications for addiction?","acceptedAnswer":{"@type":"Answer","text":"Yes. NIDA identifies medications like buprenorphine and naltrexone as a core component of evidence-based treatment, especially for opioid and alcohol use disorders. If a program dodges the question or frames medication as opposed to \"real\" recovery, that's a philosophy overriding the evidence. Ask who prescribes, whether it's on site or coordinated, and what happens if someone arrives already stabilized."}},{"@type":"Question","name":"How quickly should someone connect to the next level of care after detox or residential treatment?","acceptedAnswer":{"@type":"Answer","text":"CMS's continuity-of-care measure expects a qualifying follow-up service, an outpatient visit, IOP encounter, partial hospitalization, telehealth session, or filled SUD prescription, within 7 days of discharge from medically managed withdrawal, with 14 days as the outer window. Insist the next appointment is booked before discharge, not handed over as a phone number on paper."}},{"@type":"Question","name":"Is intensive outpatient (IOP) really as effective as residential treatment?","acceptedAnswer":{"@type":"Answer","text":"When people are matched to the right level of care, yes. A systematic review of IOPs found that 50% to 70% of participants reported abstinence at follow-up, and outcomes did not meaningfully differ between inpatient and outpatient settings. IOP isn't a downgrade. It's an evidence-based destination when the clinical structure, medication access, and monitoring are actually in place."}},{"@type":"Question","name":"How long should aftercare or continuing care last to protect against relapse?","acceptedAnswer":{"@type":"Answer","text":"The peer-reviewed continuing care literature suggests at least 3 to 6 months, and often up to 12 months, of real clinical contact before the relapse risk curve meaningfully flattens. A monthly alumni Zoom is community, not continuing care. Ask a program what clinical involvement looks like at month four, month eight, and month twelve, and who triggers a step-up in care."}},{"@type":"Question","name":"What questions should I ask when evaluating a treatment center for a family member?","acceptedAnswer":{"@type":"Answer","text":"Use NIDA's core five and SAMHSA's 12 as your backbone. Ask about accreditation, which evidence-based therapies clinicians actually deliver, medication access, how the first appointment after detox gets booked, what continuing care looks like at six months, how families are brought into the clinical work, and what percentage of clients complete the level of care they started. Vague answers are answers."}}]}]

Relapse Doesn't Mean the End Of Your Journey

For individuals, families, and professionals who’ve seen how easy it is to fall back into old patterns, the right program makes the difference. Oregon Trail Recovery in Portland offers clinically grounded, outcomes-driven care designed to help people rebuild their lives—not just get through treatment.

‍Reach out today to explore programs that support real, long-term sobriety.
Verify Benefits